Webinars
We want to help you discover just how much you can benefit from using mass spectrometry for HCP analysis and ELISA coverage analysis. Therefore, below you have access to a number of short on-demand webinars – which you can watch when it suits your schedule.
mAb HCP Control Strategy: Experiences from an “off-ELISA” road
43:47
Webinar: Problematic HCP impurities can stop your biologics project!
45:13
mAb HCP Control Strategy: Experiences from an “off-gel” road
39:32
ELISA reagent characterization using advanced LC-MS methods
44:09
Exclusive Q&A with Bryant McLaughlin, CMC Executive, USA
33:03
LC-MS HCP assay validation and GMP release testing for complex samples
50:34
The Principles of Mass Spec for HCP Analysis
22:50
Analyzing vaccine purity – without an HCP ELISA
46:45
#Rethink your
HCP strategy
33:30
Moving LC-MS analysis into a GMP environment
39:46
HCP analysis using LC-MS – for data-driven process development
30:48
How to monitor impurities and ensure consistent gene therapies
34:45
Why do we need orthogonal HCP analysis for mAbs?
24:42
Are you ready for FDA questions about impurities?
35:39
Comparison of impurity profiles – and problematic HCPs – in mAbs
35:39
Design the optimal strategy for analyzing Host Cell Proteins
32:13
3 reasons to check the coverage of your HCP-ELISA
33:10
Talk to us
Whatever protein-related challenge or question you may have, we would love to help. Our experts can help you decide on the best analytical approach for your project by email or online meeting - providing advice without obligation.